271 related articles for article (PubMed ID: 33224846)
1. Active surveillance for low-risk small papillary thyroid cancer in North American countries: past, present and future (bridging the gap between North American and Asian practices).
Pusztaszeri MP; Tamilia M; Payne RJ
Gland Surg; 2020 Oct; 9(5):1685-1697. PubMed ID: 33224846
[TBL] [Abstract][Full Text] [Related]
2. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
3. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
4. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
5. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
[TBL] [Abstract][Full Text] [Related]
6. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer.
Sawka AM; Ghai S; Tomlinson G; Rotstein L; Gilbert R; Gullane P; Pasternak J; Brown D; de Almeida J; Irish J; Chepeha D; Higgins K; Monteiro E; Jones JM; Gafni A; Goldstein DP
BMJ Open; 2018 Apr; 8(4):e020298. PubMed ID: 29654030
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance of low-risk papillary thyroid microcarcinomas.
Ito Y; Miyauchi A
Gland Surg; 2020 Oct; 9(5):1663-1673. PubMed ID: 33224844
[TBL] [Abstract][Full Text] [Related]
8. A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Tomlinson G; Baxter NN; Corsten M; Imran SA; Bissada E; Lebouef R; Audet N; Brassard M; Zhang H; Gupta M; Nichols AC; Morrison D; Johnson-Obeski S; Prisman E; Anderson D; Chandarana SP; Ghaznavi S; Jones J; Gafni A; Matelski JJ; Xu W; Goldstein DP;
Front Endocrinol (Lausanne); 2021; 12():686996. PubMed ID: 34194396
[TBL] [Abstract][Full Text] [Related]
9. Can Active Surveillance be an Alternative to Surgery in Papillary Thyroid Microcarcinoma?: The Current Situation Worldwide.
Aygün N; İşgör A; Uludağ M
Sisli Etfal Hastan Tip Bul; 2018; 52(4):233-243. PubMed ID: 32774084
[TBL] [Abstract][Full Text] [Related]
10. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
11. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Griffin A; Brito JP; Bahl M; Hoang JK
Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
[TBL] [Abstract][Full Text] [Related]
12. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
[TBL] [Abstract][Full Text] [Related]
13. Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option.
Ito Y; Miyauchi A; Kudo T; Oda H; Yamamoto M; Sasai H; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Miya A
Thyroid; 2018 Apr; 28(4):488-495. PubMed ID: 29608416
[TBL] [Abstract][Full Text] [Related]
14. Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?
Liu Q; Song M; Zhang H
J Cancer; 2024; 15(4):1009-1020. PubMed ID: 38230222
[TBL] [Abstract][Full Text] [Related]
15. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
Ito Y; Miyauchi A; Oda H
Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
Ito Y; Miyauchi A
Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
[No Abstract] [Full Text] [Related]
17. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
18. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
Bi J; Lyu PF; Wang Y; Zhang H
Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
[TBL] [Abstract][Full Text] [Related]
19. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
20. Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.
Krajewska J; Kukulska A; Oczko-Wojciechowska M; Kotecka-Blicharz A; Drosik-Rutowicz K; Haras-Gil M; Jarzab B; Handkiewicz-Junak D
Front Endocrinol (Lausanne); 2020; 11():571421. PubMed ID: 33123090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
